Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Pharmaceutical deals crucial to offsetting US$2.5bn cost of novel drug development

The shift from small molecules to large molecules, such as antibodies and proteins, has created new opportunities in the pharmaceutical industry

Ingredients | Regulatory | R and D | Finance

BioAtla and Pfizer to develop a new class of antibody therapeutics

Agreement combines BioAtla's conditionally active biologic (CAB) antibodies with Pfizer's proprietary ADC payloads

Ingredients | Drug Delivery | R and D | Therapeutic Sector | Finance

Bio-Rad launches antibodies validated specifically for western blotting

Detailed validation protocols streamline optimisation and validation, saving time and reagents

Ingredients | R and D | Measurement and Analysis

Alligator Bioscience benefits from Cobra’s maxXpress platform

Cobra developed the cell line to express agonistic CD40 antibodies for an immuno-oncology application using its maxXpress platform

Ingredients | Europe | Regulatory | Biotechnology

Antibody search engine spins out from University of Bath in UK

CiteAb lists more than 1.5 million antibodies from 92 suppliers

Ingredients | Europe | R and D